English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > がん > 世界の皮膚癌治療薬市場
カテゴリ
医薬品 (4962)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

世界の皮膚癌治療薬市場

Global Skin Cancer Therapeutics Markets

発行 Frost & Sullivan
出版日 2009年10月 商品コード 102289
ページ情報 英文  
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service analyses the global skin cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recommendations.

Table of Contents

1. Executive Summary

Overview

  • Overview of the Global Skin Cancer Therapeutics Markets

2. Glossary of Terms

List of Terms

  • Abbreviations

3. Research Methodology

Research Objectives and Scope

  • Methodology
  • Assumptions and Limitations
  • Objective
  • Segment Scope
  • Geographical Scope

4. Skin Cancer Overview

Introduction

  • Disease Characteristics
  • Epidemiology
  • Risk Factors
  • Diagnosis
  • Staging & Prognosis
  • Major Sub-types

Patient Forecasts

  • Patient Forecasts of Skin Cancer in the World
  • Patient Forecasts of Skin Cancer in the U.S
  • Patient Forecasts of Skin Cancer in the European Union
  • Patient Forecasts of Skin Cancer in Australia

5. Industry Challenges

Industry Challenges for the Global Skin Cancer Therapeutics Market

  • Issues and Challenges

6. Current Treatment Options in the Global Skin Cancer Market

Current Therapies

  • Analysis of Key Current Therapies

7. Key Trends in the Global Skin Cancer Therapeutics Market

Analysis of Key Global Trends in the Skin Cancer Therapeutics Market

  • Key Trends and Analysis

8. Market Engineering Research of the Global Skin Cancer Therapeutics Market

Analysis of the Global Skin Cancer Therapeutics Market

  • Market Drivers
  • Market Restraints

9. Geographical Analysis of the Melanoma Therapeutics Market

Global Melanoma Market

  • Global Melanoma Therapeutics Market Overview
  • Market Engineering Measurements
  • Revenue Forecasts of the Global Melanoma Therapeutics Market

U.S Melanoma Market

  • U.S. Melanoma Therapeutics Market Overview
  • Market Engineering Measurements
  • Revenue Forecasts of the U.S. Melanoma Therapeutics Market

European Union Melanoma Market

  • European Union Melanoma Therapeutics Market Overview
  • Market Engineering Measurements
  • Revenue Forecasts of the European Union Melanoma Therapeutics Market

Rest-of-World Melanoma Market

  • Rest-of-World Melanoma Therapeutics Market Overview
  • Market Engineering Measurements
  • Revenue Forecasts of the Rest-of-World Melanoma Therapeutics Market

10. Emerging Treatment Options in the Global Skin Cancer Market

Pipeline Analysis

  • Emerging Treatment Options and Pipeline Analysis

11. Strategic Recommendations for the Global Skin Cancer Therapeutics Market

Market Engineering Recommendations

  • Strategic Recommendations

12. Decision Support Databases

Databases for Analysis

  • Cancer Cases
  • Government Healthcare Expenditure
  • Private Healthcare Expenditure
  • Per Capita Healthcare Expenditure
  • Per cent Healthcare Expenditure in GDP
  • Total Healthcare Expenditure
  • Pharmaceutical Market
  • Pharmaceutical R&D Expenditure
  • Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market
  • Number of Biotechnology Companies
  • Venture Capital Investment in Biotech R & D
  • Government R&D Investment in Biotechnology
  • Per cent of Government Investment in Biotechnology R&D
  • Population 65 Plus
  • Per cent Population 65 Plus
Back to Top